Compile Data Set for Download or QSAR
Report error Found 136 Enz. Inhib. hit(s) with all data for entry = 12349
TargetFatty-acid amide hydrolase 1(Human)
Psy Therapeutics

US Patent
LigandPNGBDBM81356(PF-3845, 10 | US20240308985, Comparator TableD2.2)
Affinity DataIC50: 14nMAssay Description:MAGL inhibitor compounds were also counter-screened for FAAH inhibition potency using the following assay. Assessment of FAAH inhibition was performe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696676(US20240308985, Compound 126)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696683(US20240308985, Compound 128)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696741(US20240308985, Compound 365)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696747(US20240308985, Compound 366)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696821(US20240308985, Compound 414 | US20240308985, Compo...)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696823(US20240308985, Compound 417)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696824(US20240308985, Compound 440 | US20240308985, Compo...)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696826(US20240308985, Compound 444)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696827(US20240308985, Compound 446)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696829(US20240308985, Compound 473)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696831(US20240308985, Compound 475)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696833(US20240308985, Compound 477)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696835(US20240308985, Compound 488)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696838(US20240308985, Compound 491)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696840(US20240308985, Compound 493)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696842(US20240308985, Compound 520)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696843(US20240308985, Compound 525)
Affinity DataIC50: 50nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696640(US20240308985, Compound 125)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696730(US20240308985, Compound 140)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696731(US20240308985, Compound 141)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696736(US20240308985, Compound 185)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696807(US20240308985, Compound 367)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696809(US20240308985, Compound 371)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696811(US20240308985, Compound 376)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696817(US20240308985, Compound 407)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696818(US20240308985, Compound 408)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696819(US20240308985, Compound 410)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696822(US20240308985, Compound 415)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696828(US20240308985, Compound 472)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696832(US20240308985, Compound 476)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696836(US20240308985, Compound 489)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696837(US20240308985, Compound 490)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696839(US20240308985, Compound 492)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696841(US20240308985, Compound 519)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696844(US20240308985, Compound 526)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696849(US20240308985, Compound 177)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696856(US20240308985, Compound 418)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696866(US20240308985, Compound 448)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696869(US20240308985, Compound 451)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696872(US20240308985, Compound 455)
Affinity DataIC50: 100nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696636(US20240308985, Compound 120)
Affinity DataIC50: 325nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696810(US20240308985, Compound 373)
Affinity DataIC50: 325nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696815(US20240308985, Compound 381)
Affinity DataIC50: 325nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696820(US20240308985, Compound 411)
Affinity DataIC50: 325nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696830(US20240308985, Compound 474)
Affinity DataIC50: 325nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696821(US20240308985, Compound 414 | US20240308985, Compo...)
Affinity DataIC50: 325nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696852(US20240308985, Compound 203)
Affinity DataIC50: 325nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696855(US20240308985, Compound 374)
Affinity DataIC50: 325nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

TargetMonoglyceride lipase [2-303](Homo sapiens (Human))
Psy Therapeutics

US Patent
LigandPNGBDBM696861(US20240308985, Compound 425)
Affinity DataIC50: 325nMAssay Description:MAGL Inhibition was measured by the following assay. Monoacylglycerol Lipase (MAGL) inhibition was measured using recombinant MAGL enzyme (aa 2-303 R...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 136 total ) | Next | Last >>
Jump to: